Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics

NCT02579434 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02579434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics
Lead sponsor
Seoul National University Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2014
Completion date
April 30, 2016
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers